OFIX
Orthofix Medical Inc.
-0.19 (-2.13%)8.71USD52.0K成交股數355M市值–本益比(近四季)0.4股價營收比+3.9%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 211M+4% | 197M+2% | 220M+12% | 206M+4% | 203M+8% | 194M-3% | 197M+7% | 199M+6% | 189M | 200M | 184M | 187M |
| 營業成本 | 61.2M | 57.2M | 63.6M | 57.1M | 63.6M | 72.0M | 61.6M | 63.9M | 61.4M | 63.8M | 64.2M | 67.5M |
| 毛利 | 150M+7% | 140M+15% | 156M+16% | 149M+10% | 140M+10% | 122M-11% | 135M+13% | 135M+13% | 127M | 137M | 120M | 120M |
| 毛利率 | 71.0% | 70.9% | 71.1% | 72.2% | 68.7% | 62.8% | 68.7% | 67.8% | 67.5% | 68.2% | 65.1% | 63.9% |
| 研發費用 | 15.9M | 15.3M | 15.4M | 14.8M | 15.9M | 19.8M | 17.3M | 18.0M | 19.5M | 18.9M | 18.6M | 19.4M |
| 銷售管理費用 | 138M | 135M | 137M | 148M | 136M | 133M | 130M | 134M | 132M | 420M | 27.1M | 34.2M |
| 營業利益 | −8.1M-49% | −14.4M-70% | 494K-103% | −17.0M-32% | −16.0M-45% | −48.9M+167% | −18.9M-23% | −24.9M-32% | −29.3M | −18.3M | −24.4M | −36.6M |
| 營業利益率 | -3.9% | -7.3% | 0.2% | -8.3% | -7.9% | -25.2% | -9.6% | -12.5% | -15.6% | -9.1% | -13.3% | -19.6% |
| 稅後淨利 | −15.8M+12% | −20.9M-61% | −2.2M-92% | −22.8M-32% | −14.1M-61% | −53.1M+139% | −27.4M-5% | −33.4M-15% | −36.0M | −22.2M | −28.9M | −39.4M |
| 淨利率 | -7.5% | -10.6% | -1.0% | -11.1% | -6.9% | -27.4% | -13.9% | -16.8% | -19.1% | -11.1% | -15.7% | -21.1% |
| 稀釋 EPS | -0.39+8% | -0.52-61% | -0.05-93% | -0.57-35% | -0.36-62% | -1.35+137% | -0.71-8% | -0.88-18% | -0.95 | -0.57 | -0.77 | -1.07 |
| 稀釋股數 | 40.9M | 40.5M | 39.6M | 39.8M | 39.5M | 39.2M | 38.5M | 38.0M | 37.7M | 36.7M | 37.2M | 36.8K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 104M | 120M | 82.0M | 62.9M | 65.6M | 58.0M | 30.1M | 26.4M | 27.0M | 33.1M | 33.7M | 37.6M |
| 應收帳款 | 136M | 138M | 136M | 131M | 130M | 132M | 125M | 125M | 126M | 128M | 114M | 112M |
| 存貨 | 184M | 178M | 172M | 174M | 173M | 174M | 206M | 210M | 219M | 222M | 222M | 222M |
| 總資產 | 873M | 887M | 851M | 833M | 837M | 823M | 868M | 882M | 906M | 925M | 906M | 901M |
| 有息負債 | 222M | 221M | 157M | 157M | 157M | 157M | 112M | 113M | 115M | 93.1M | 70.0M | 51.0M |
| 總負債 | 444M | 451M | 401M | 390M | 379M | 365M | 342M | 336M | 336M | 327M | 290M | 261M |
| 股東權益 | 429M | 435M | 450M | 442M | 458M | 458M | 526M | 546M | 570M | 599M | 615M | 640M |
| 負債比 | 50.8% | 50.9% | 47.1% | 46.9% | 45.2% | 44.3% | 39.4% | 38.1% | 37.1% | 35.3% | 32.0% | 29.0% |
| 淨現金(現金 − 有息負債) | −118M | −101M | −75.4M | −94.4M | −91.4M | −98.9M | −82.2M | −86.9M | −88.1M | −60.0M | −36.3M | −13.4M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −17.6M-4% | – | – | – | −18.4M | – | – | −18.6M | – | – | – |
| 資本支出 | – | 10.7M | – | – | – | 6.7M | – | – | 10.5M | – | – | – |
| 自由現金流 | – | −28.3M+13% | – | – | – | −25.1M | – | – | −29.1M | – | – | – |
| 折舊攤銷 | 13.3M | 13.5M | 13.1M | 12.9M | 16.9M | 34.4M | 15.2M | 14.0M | 14.9M | 14.0M | 13.1M | 13.3M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -14.4% | – | – | – | -13.0% | – | – | -15.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 822M
| Global Spine | 688M | 83.6% | +1.8% |
|---|---|---|---|
| Global Limb Reconstruction | 135M | 16.4% | +8.4% |
地區2025 年度 · 938M
| 美國 | 684M | 72.9% | +1.7% |
|---|---|---|---|
| 美國以外 | 138M | 14.7% | +9.1% |
| 其他國家 | 76.7M | 8.2% | +15.6% |
| 英國 | 13.3M | 1.4% | +19.2% |
| 法國 | 12.0M | 1.3% | -10.7% |
| 德國 | 9.1M | 1.0% | +1.1% |
| 巴西 | 4.8M | 0.5% | -15.3% |
| 義大利 小計 | 22.3M | 2.4% | +6.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 822M | +2.9% | −92.2M | -11.2% | -2.33 | −1.3M |
| FY2024 | 799M | +7.1% | −126M | -15.8% | -3.30 | −9.1M |
| FY2023 | 747M | +62.1% | −151M | -20.3% | -4.12 | −106M |
| FY2022 | 461M | -0.8% | −19.8M | -4.3% | -0.98 | −32.9M |
| FY2021 | 464M | +14.2% | −38.4M | -8.3% | -1.95 | 690K |
| FY2020 | 407M | -11.6% | 2.5M | 0.6% | 0.13 | 58.8M |
| FY2019 | 460M | +1.5% | −28.5M | -6.2% | -1.51 | 13.0M |
| FY2018 | 453M | – | 13.8M | 3.0% | 0.72 | 36.3M |